Pharmacy Benefit Management

From Drug Benefit News - Health plans selling now on public exchanges for plan year 2015 have significantly higher drug copay levels than 2014 plans, according to research from AIS’s Rx Benefit Design Data (RxB), a new online subscription database. Bronze-level plans have the biggest increases, on average, in prescription drug copays for in-network retail fills on all formulary tiers. Drug copays for bronze-level plans now average $18.59 for generics, a 30.55% increase over the 2014 amount. Read more

From Drug Benefit News - Employers of participating coalitions around the country this month are getting a first look at a comprehensive tool from the National Business Coalition on Health (NBCH) comparing PBM services and may be surprised by a few of the results. Read more

Pharmacy Benefit Management Blog

By Angela Maas - January 23, 2015
After Gilead launched its hepatitis C treatment Sovaldi in late 2013 with a $1,000-per-day price tag, it seems like every day I’ve seen another article on this drug and how PBMs and payers are covering — or not covering — it. Then when the manufacturer brought Harvoni to the U.S. market in October...
By Lauren Flynn Kelly - December 29, 2014
From the exorbitant cost of new hepatitis C treatments to rising generic drug prices, payers experienced several new thorns in their side this year when it came to managing the pharmacy benefit. Let’s take a look back at some of the biggest news stories reported by Drug Benefit News. "CVS Caremark...
By Angela Maas - December 16, 2014
When the Biologics Price Competition and Innovation Act passed as part of the health reform law, it established a pathway by which biosimilar drugs could gain abbreviated approval by the FDA. But beyond creating that pathway, little else about the process was laid out in the law, leaving the...

It's quick and easy to sign up for FREE access to!

Why do I need to register?